AN OPEN-LABEL, SINGLE-ARM PHASE II STUDY OF F901318 AS TREATMENT OF INVASIVE FUNGAL INFECTIONS DUE TO LOMENTOSPORA PROLIFICANS, SCEDOSPORIUM SPP., ASPERGILUS SPP., AND OTHER RESISTANT FUNGI IN PATIENTS LACKING SUITABLE ALTERNATIVE TREATMENT OPTIONS
Principal Investigator(s)
Patterson, Thomas F
Funded by
F2G LTD
Research Start Date
Status
Active